跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10 条关于
“taldefgrobep”
全部
10
临床试验
2
药物
1
机构
0
资讯
7
去年
Biohaven's Taldefgrobep Alfa Shows Promise in Obesity Despite SMA Trial Setback
去年
Biohaven's Obesity Program Gains Analyst Confidence Despite SMA Trial Setback
去年
Biohaven Announces Third Quarter 2024 Financial Results and Business Developments
去年
FDA Sets Q3 2025 Approval Dates for Three Breakthrough Therapies Targeting Rare Diseases
去年
Scholar Rock's Stock Target Increased Following SMA Study Results
8个月前
Biohaven's BHV-7000 Fails to Meet Primary Endpoint in Phase 2 Major Depression Trial
10个月前
FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) for Spinocerebellar Ataxia